Nano-X Imaging (NASDAQ:NNOX) Given Buy Rating at D. Boral Capital

D. Boral Capital reaffirmed their buy rating on shares of Nano-X Imaging (NASDAQ:NNOX) in a research note published on Monday morning,Benzinga reports. D. Boral Capital currently has a $5.00 target price on the stock.

NNOX has been the subject of a number of other reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Friday. Cantor Fitzgerald upgraded shares of Nano-X Imaging to a “strong-buy” rating in a research report on Wednesday, March 4th. Three research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Nano-X Imaging presently has an average rating of “Buy” and a consensus target price of $5.00.

Nano-X Imaging Trading Up 4.8%

NASDAQ NNOX opened at $2.38 on Monday. Nano-X Imaging has a 1-year low of $2.11 and a 1-year high of $5.86. The company has a 50 day moving average of $2.42 and a 200-day moving average of $3.09. The company has a market cap of $155.60 million, a price-to-earnings ratio of -1.80 and a beta of 1.39.

Institutional Investors Weigh In On Nano-X Imaging

A number of hedge funds and other institutional investors have recently made changes to their positions in NNOX. Interchange Capital Partners LLC acquired a new position in Nano-X Imaging during the fourth quarter valued at approximately $28,000. Aristides Capital LLC acquired a new position in Nano-X Imaging during the fourth quarter valued at approximately $30,000. CIBC Bancorp USA Inc. acquired a new position in Nano-X Imaging during the third quarter valued at approximately $40,000. Russell Investments Group Ltd. raised its position in Nano-X Imaging by 62.1% during the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock valued at $51,000 after purchasing an additional 5,283 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new position in Nano-X Imaging during the fourth quarter valued at approximately $54,000. 21.49% of the stock is currently owned by institutional investors and hedge funds.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.